Proton Beam Therapy for Loco-Regional Control of a Recurrent Mixed Malignant Germ Cell Tumor of the Skull in a 22-Month-Old Girl

被引:1
作者
Calaminus, G. [1 ]
Goebel, U. [2 ]
Schrum, J. [3 ]
Wittkugel, O. [4 ]
Westphal, M. [5 ]
Timmermann, B. [6 ]
机构
[1] Univ Munster, D-48129 Munster, Germany
[2] Univ Dusseldorf, Coordinat Ctr Clin Studies, ESPED Surveillance Unit, Dusseldorf, Germany
[3] Univ Hosp Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany
[4] Univ Hosp Hamburg Eppendorf, Dept Neurol Diagnost & Intervent, Hamburg, Germany
[5] Univ Hosp Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany
[6] W German Protontherapy Ctr Univ Essen, Essen, Germany
来源
KLINISCHE PADIATRIE | 2010年 / 222卷 / 03期
关键词
head and neck; infants; germ cell tumors; local tumor control; proton beam therapy; COMBINATION CHEMOTHERAPY; CHILDREN; CANCER; TERATOMAS; ADOLESCENTS; CHILDHOOD; CISPLATIN; ETOPOSIDE; INTERGROUP; BLEOMYCIN;
D O I
10.1055/s-0030-1252018
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Germ cell tumors (GCT) situated in the head and neck region are very rare and occur predominantely in newborns or young infants. Recurrent CTs are often resectable only by mutilating surgery and the need for alternative treatment strategies is obvious. In this situation radiation therapy is the most important treatment option for loco-regional tumor control, but bear in this area the risk of possible impairment of brain function and face deformation as long term effects. Case report: In a girl with a connatal expansive growing teratoma of the skull the tumor recurred in spite of repeated surgery as mixed malignant GCT at the age of 15 months. Tumor control could not be achieved with chemotherapy and additional surgery seemed not promising. Therefore high dose proton beam therapy (PT) (54 Gy) has been administered to the child at the age of 22 months and led to local tumor control with only mild side effects. Conclusion: PT treatment may be an option for specific clinical conditions in germ cell tumors where local tumor control cannot be achieved by chemotherapy and/or surgery and long lasting side effects of conventional radiotherapy due to tumor localization and age have to be considered. However, PT should be implemented in treatment protocols for specific situations to guarantee supervised application, central documentation and follow-up.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 19 条
  • [1] The growing teratoma syndrome:: results of therapy and long-term follow-up of 33 patients
    André, F
    Fizazi, K
    Culine, S
    Droz, JP
    Taupin, P
    Lhommé, C
    Terrier-Lacombe, MJ
    Théodore, C
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) : 1389 - 1394
  • [2] Germ Cell Tumors of the Head and Neck: Report From the MAKEI Study Group
    Bernbeck, Beate
    Schneider, Dominik T.
    Bernbeck, Benedikt
    Koch, Susanne
    Teske, Carmen
    Lentrodt, Juergen
    Harms, Dieter
    Goebel, Ulrich
    Calaminus, Gabriele
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 52 (02) : 223 - 226
  • [3] Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors:: A prospective evaluation of 71 patients treated in the German cooperative protocols maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89
    Calaminus, G
    Schneider, DT
    Bökkerink, JPM
    Gadner, H
    Harms, D
    Willers, R
    Göbel, U
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) : 781 - 786
  • [4] Survival after an Antiangiogenetic Therapy and Surgery in a Wide Spread Growing Teratoma Originating from a Testicular Mixed Malignant Germ Cell Tumor
    Calaminus, G.
    Schneider, D. T.
    Weissbach, L.
    Schoenberger, S.
    Okpanyi, V.
    Leuschner, I.
    Poremba, C.
    Goebel, U.
    [J]. KLINISCHE PADIATRIE, 2009, 221 (03): : 136 - 140
  • [5] Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: A pediatric intergroup study - Pediatric Oncology Group 9049 and Children's Cancer Group 8882
    Cushing, B
    Giller, R
    Cullen, JW
    Marina, NM
    Lauer, SJ
    Olson, TA
    Rogers, PC
    Colombani, P
    Rescorla, F
    Billmire, DF
    Vinocur, CD
    Hawkins, EP
    Davis, MM
    Perlman, EJ
    Castleberry, RP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (13) : 2691 - 2700
  • [6] The Cohort of Long-term Survivors at the German Childhood Cancer Registry
    Debling, D.
    Spix, C.
    Blettner, M.
    Michaelis, J.
    Kaatsch, P.
    [J]. KLINISCHE PADIATRIE, 2008, 220 (06): : 371 - 377
  • [7] The malignant potential of teratomas in infancy and childhood:: The MAKEI experiences in non-testicular teratoma and implications for a new protocol
    Gobel, U.
    Calaminus, G.
    Schneider, D. T.
    Koch, S.
    Harms, D.
    [J]. KLINISCHE PADIATRIE, 2006, 218 (06): : 309 - 314
  • [8] Göbel U, 2001, J CLIN ONCOL, V19, P1943
  • [9] Pathology and molecular biology of teratomas in childhood and adolescence
    Harms, D.
    Zahn, S.
    Goebel, U.
    Schneider, D. T.
    [J]. KLINISCHE PADIATRIE, 2006, 218 (06): : 296 - 302
  • [10] HAWKINS E, 1993, AM J PEDIAT HEMATOL, V15, P406